Trial intelligence / Profile preview

Lamaline vs Dafalgan Codeine in Knee Osteoarthritis

NCT00264225Phase 3Completed

Sponsor
Solvay
Start
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of paracetamol + opium powder + caffeine in knee osteoarthritis (OA), sponsored by Solvay. Primary endpoint: Pain intensity assessed by Visual Analogue Scale at 10 days. Started Dec 2005; status: completed.

02

Drugs

paracetamol + opium powder + caffeine
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00264225.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00264225.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call